The hunger switch Ozempic doesn’t actually turn off
After publishing: 1 headline quietly rewritten1 change
- ABC (Spain)seen 23 Aug, 05:07headline rewritten
Post-Ozempic: una pastilla que adelgaza e imita los beneficios del ejercicioLa pastilla que adelgaza e imita los beneficios del ejercicio
What it is about
Who published it, and when
How it spread - 17 original reports, 2 reprints
Tue, 11 August 2026
1 report- bakeryandsnacks.com00:00first to report
A new Yale study challenges what we thought we knew about how Ozempic and other GLP-1 drugs sustain weight loss – here's what the science means for food manufacturers.
Sat, 15 August 2026
2 reports- Google News - Top Stories02:04
GLP-1s May Be Working in an Entirely Different Way Than We Thought ScienceAlert Scientists solve the mystery of a brain “switch” that can trigger weight loss in opposite ways ScienceDaily New study may change how we think about GLP-1s YaleNews GLP-1 obesity drugs activate hunger neurons to drive fat loss 동아사이언스 New Weight Loss Pills Barely Worked in Mice Until Scientists Uncovered a Brain Circuit Controlling Cravings Medical Daily
- Index.hr (Croatia)20:17
NOVA studija otkriva da Ozempic djeluje i putem "neurona gladi" koji potiču tijelo na aktivnije trošenje masnih zaliha i dugoročno mršavljenje.
Sun, 16 August 2026
1 report- derstandard.at16:30
Pharma’s newest obsession involves mimicking the system that keeps people awake
Wed, 19 August 2026
1 report- El Mundo (Spain)22:13
Con los fármacos GLP-1 amenazando miles de millones de dólares en ventas, los fabricantes de alimentos envasados están probando formas de ganarse a quienes ya no tienen tanto apetito Leer
Thu, 20 August 2026
1 report- ABC (Spain)22:45edited after publishing
previously
Post-Ozempic: una pastilla que adelgaza e imita los beneficios del ejercicioDurante décadas, adelgazar con un tratamiento parecía más una promesa que una realidad, casi como la ilusión que se vendía con las cremas antiedad. Hasta que llegaron Ozempic y otros medicamentos de la familia GLP-1. El mundo ahora se divide entre los que pierden peso con un pinchazo y los que siguen esforzándose con dieta y ejercicio. Pero si conoce a alguien en tratamiento, sabrá que perder peso con estos fármacos tampoco es tan sencillo. Muchos abandonan la medicación por sus efectos...
Fri, 21 August 2026
1 report- wxyz.com15:03
Vanderbilt researchers are studying whether GLP-1 drugs used for diabetes and obesity can help prevent opioid relapse.
2 reprints
- wkbw.com21 Aug, 15:03their copy
- katc.com21 Aug, 15:03their copy
Sat, 22 August 2026
1 report- El País (Spain)03:30
Usuarios de medicamentos GLP-1 se sinceran en las redes sobre su anhedonia, un efecto secundario que les impide disfrutar o interesarse por las actividades que antes les resultaban gratificantes
Sun, 23 August 2026
1 report- juneauempire.com15:30
In the ongoing debate surrounding America’s metabolic crisis, we have reached a bizarre cultural paradox. On one side, we are witnessing the medicalization of appetite: millions of adults are turning to GLP-1 receptor agonists like Ozempic and Wegovy to synthetically force their bodies into feeling full. On the other, public health dialogue remains stubbornly fixated on lecturing individuals about willpower.
Mon, 24 August 2026
6 reports- sci.news17:31
Scientists have identified a decades-old chemical compound as a promising new candidate for treating obesity and related metabolic diseases.
- The Hill18:53
From unexpected babies to "Ozempic teeth," the ultra-popular class of GLP-1 medications are turning out to have a few unanticipated side effects. Emerging research shows the drugs, which have proven effective in treating obesity and diabetes, may also be useful in treating addiction.
- iheart.com20:04
GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.
- iheart.com20:04
GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.
- iheart.com20:04
GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.
- iheart.com20:04
GLP-1 medications, like Ozempic and Wegovy, may treat addiction by reducing cravings. A study shows they lower the risk of substance use disorders and severe harm. Researchers suggest clinical trials to explore this potential further.
Tue, 25 August 2026
1 report- mykisscountry937.com09:19
Several unpublished but very beneficial side effects appear to be connected to the use of those medications.
Fri, 28 August 2026
1 report- aol.com11:00
This is certainly enlightening.